Display Settings:

Format

Send to:

Choose Destination
Trends Pharmacol Sci. 2004 May;25(5):280-9.

K+ channels as targets for specific immunomodulation.

Author information

  • 1Department of Physiology and Biophysics, University of California, Irvine, CA 92697, USA. gchandy@uci.edu

Abstract

The voltage-gated Kv1.3 channel and the Ca(2+)-activated IKCa1 K(+) channel are expressed in T cells in a distinct pattern that depends on the state of lymphocyte activation and differentiation. The channel phenotype changes during the progression from the resting to the activated cell state and from naïve to effector memory cells, affording promise for specific immunomodulatory actions of K(+) channel blockers. In this article, we review the functional roles of these channels in both naïve cells and memory cells, describe the development of selective inhibitors of Kv1.3 and IKCa1 channels, and provide a rationale for the potential therapeutic use of these inhibitors in immunological disorders.

PMID:
15120495
[PubMed - indexed for MEDLINE]
PMCID:
PMC2749963
Free PMC Article

Images from this publication.See all images (5)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk